Assembly Biosciences (ASMB) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to -$232.6 million.
- Assembly Biosciences' Enterprise Value fell 14491.54% to -$232.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$232.6 million, marking a year-over-year decrease of 14491.54%. This contributed to the annual value of -$112.1 million for FY2024, which is 1394.89% up from last year.
- As of Q3 2025, Assembly Biosciences' Enterprise Value stood at -$232.6 million, which was down 14491.54% from -$75.0 million recorded in Q2 2025.
- In the past 5 years, Assembly Biosciences' Enterprise Value ranged from a high of -$46.2 million in Q3 2023 and a low of -$232.6 million during Q3 2025
- Over the past 5 years, Assembly Biosciences' median Enterprise Value value was -$112.1 million (recorded in 2024), while the average stood at -$122.0 million.
- As far as peak fluctuations go, Assembly Biosciences' Enterprise Value skyrocketed by 5746.93% in 2023, and later plummeted by 14491.54% in 2025.
- Over the past 5 years, Assembly Biosciences' Enterprise Value (Quarter) stood at -$146.6 million in 2021, then skyrocketed by 37.52% to -$91.6 million in 2022, then crashed by 42.18% to -$130.2 million in 2023, then increased by 13.95% to -$112.1 million in 2024, then tumbled by 107.49% to -$232.6 million in 2025.
- Its Enterprise Value stands at -$232.6 million for Q3 2025, versus -$75.0 million for Q2 2025 and -$91.0 million for Q1 2025.